Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza - sprookjes - yvandenbroek - TriplyDB

Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza

Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza

http://www.wikidata.org/entity/Q28757651

about

sameAs

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells The influenza virus enigma Rapid cloning of high-affinity human monoclonal antibodies against influenza virus Current and future antiviral therapy of severe seasonal and avian influenza Convalescent plasma: new evidence for an old therapeutic tool?A crucial role for infected-cell/antibody immune complexes in the enhancement of endogenous antiviral immunity by short passive immunotherapy Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection What is the optimal therapy for patients with H5N1 influenza?H5N1 whole-virus vaccine induces neutralizing antibodies in humans which are protective in a mouse passive transfer model Prevention and treatment of influenza with hyperimmune bovine colostrum antibody Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases.Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice.An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infection Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.Human monoclonal antibodies targeting the haemagglutinin glycoprotein can neutralize H7N9 influenza virus.Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses.A potent broad-spectrum protective human monoclonal antibody crosslinking two haemagglutinin monomers of influenza A virus Combination therapy using chimeric monoclonal antibodies protects mice from lethal H5N1 infection and prevents formation of escape mutants.Avian influenza: the threat of the 21st century.Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine.Acquired heterosubtypic antibodies in human immunity for avian H5N1 influenza.Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses.Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice.Intranasal delivery of an IgA monoclonal antibody effective against sublethal H5N1 influenza virus infection in mice Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.Cross-protection of chicken immunoglobulin Y antibodies against H5N1 and H1N1 viruses passively administered in mice A novel monoclonal antibody effective against lethal challenge with swine-lineage and 2009 pandemic H1N1 influenza viruses in mice.H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans.A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.Passive immune neutralization strategies for prevention and control of influenza A infections.Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem.Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunity Infection with 2009 H1N1 influenza virus primes for immunological memory in human nose-associated lymphoid tissue, offering cross-reactive immunity to H1N1 and avian H5N1 viruses.

P2860

Q21562507-D25D66C8-1EA7-4EB3-A11C-924609283657 Q24616614-CFC172D0-BA82-488B-B0C1-952F156FDDFE Q24644672-E6D6D137-8581-4418-9206-E94E91C8B059 Q24656164-48C54E64-9149-4366-8C95-4B7B62F45328 Q26775412-5EAE594D-59EA-425A-8C70-3679FA17AFB0 Q27314576-758D6C64-2264-4FD5-9D4B-FA1EECDE8E62 Q27671619-CC3800B2-6574-46A5-89D2-86D6DF65FA16 Q28308105-85455924-6A51-4B32-A25A-7C89A51003D1 Q28475630-313D86D2-DB15-481D-82AC-BFCB98E2F759 Q28741304-6B3A9ABD-62B1-4168-86C7-8F57BBB46F88 Q28748705-F66D4D6C-99C3-4449-80C1-312ADA3C55E3 Q30222441-AAEA57E8-F91D-4D05-89A3-141882EFA53B Q30227194-3E880FC4-8654-44EE-B7BC-EE122FCF1A05 Q30361437-BC9602F5-D249-4B3C-B2BD-C8E8EF3D5A7E Q30365380-AF734EE4-EC68-470F-B123-7A427836AAFF Q30371674-1724DB13-59A6-4ED0-B00F-E0E037BE9155 Q30372987-F3046199-209A-4814-8613-556023884F8D Q30373175-9F46806B-C885-4838-B754-80A759B1905B Q30376292-8121050E-6307-4E57-B394-A7434B1309AC Q30376814-0BE61B3C-CF08-4494-BAF6-A6F22EC219F4 Q30377012-8CFF9FE3-5CD0-456A-A0C9-9C1DB5D8CDCF Q30377663-A5A3D6C5-C80E-44B7-8AE3-64A7D1C3B7E9 Q30378353-10E16899-CE9F-415A-9B05-4B15E5DC659E Q30378572-860315A5-8C57-40AF-9EBE-CE8807F37B10 Q30384441-AA399407-063D-4CD5-87D8-FAA829BF1648 Q30384878-4F21AD73-3F66-40AE-B6D2-ECB3FFC59AC8 Q30385394-E2F2191B-5807-48B7-AA35-369F9759EF12 Q30387739-34F44E97-CD69-45C6-B12C-BC880EA753C3 Q30388253-AE350856-54DB-4CB9-ACD2-A96E523F3ACE Q30391974-286E8FB2-2C3A-45D4-BFE4-1C23324B2A64 Q30398435-12518E9C-92E1-4CA3-A933-A7FAAB9B7C9B Q30398715-3023F9EB-271C-44B6-A43F-48533B1DF53D Q30403137-17B7584D-AE43-4982-A743-424FC25C16A7 Q30405066-C9A1353C-E658-474A-BFD2-EAE9A2FAE403 Q30406365-BBF3FB65-86C3-4035-BEC5-8FDBFC1E2F90 Q30411637-F1A76D20-64AF-4EDF-A3E0-7AE0C8FCAB93 Q30413158-1B4E4A47-3A43-4FE1-8755-E9B5964BB39B Q30416784-FD187F24-63A2-47F3-A6E1-F7A51CD95173 Q30421682-7381D050-F0BB-4BE7-BBB7-618B44392612 Q30427946-6DD26D03-5AF7-47FC-8047-2510F2990233

P2860

Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza

http://www.wikidata.org/entity/Q28757651

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Prophylactic and therapeutic e ...... ibodies against H5N1 influenza

@ast

Prophylactic and therapeutic e ...... ibodies against H5N1 influenza

@en

Prophylactic and therapeutic e ...... ibodies against H5N1 influenza

@nl

type

label

Prophylactic and therapeutic e ...... ibodies against H5N1 influenza

@ast

Prophylactic and therapeutic e ...... ibodies against H5N1 influenza

@en

Prophylactic and therapeutic e ...... ibodies against H5N1 influenza

@nl

prefLabel

Prophylactic and therapeutic e ...... ibodies against H5N1 influenza

@ast

Prophylactic and therapeutic e ...... ibodies against H5N1 influenza

@en

Prophylactic and therapeutic e ...... ibodies against H5N1 influenza

@nl

P1433

Q28757651-69C873DB-0A1C-48E1-A358-ED5E6ED423BE

P1476

Q28757651-42FD28AE-821C-4416-B4C0-2B8AF37E8877

P2093

Q28757651-0033A2F6-31DA-450A-BCA4-E9108832AE04

Q28757651-78D30529-B095-482C-96CB-73B703EF1B17

Q28757651-8F11B021-F3B7-40F1-9B74-63D806C78224

Q28757651-95A3F854-556D-45A9-B85F-AEF8BF3137CC

Q28757651-B0ABD2DB-7BAA-47BF-9708-172F02EA2E69

Q28757651-EB547A86-A993-4A27-81F8-26CC4C2AB09E

P2860

Q28757651-096FB4C0-EE28-497D-8D44-01D6831B9EBB

Q28757651-14313EA3-251E-4A68-AB5E-8431A2F4AEF6

Q28757651-1906ADCE-B9A0-471F-9647-B5A5A953B225

Q28757651-2492864C-330C-402F-80D9-AC773BB66FD1

Q28757651-26088EE3-1031-4C40-BD4A-568B963B236C

Q28757651-27703631-EAB3-417E-B79F-6D03A5F257F5

Q28757651-2CBD41ED-E1D0-4A41-B56B-2C45DE0D204D

Q28757651-3A4F3FE9-5A55-4F7A-A9EB-F0DB7061DD8A

Q28757651-41518DDE-5483-4917-A065-AE71A2183DD3

Q28757651-5A1D15BB-4E49-408B-A200-5205B0F8941C

P304

Q28757651-DA5C27F6-B23F-4C5F-BE48-5091D54C62CC

P31

Q28757651-84EA6731-D4B5-49E7-99E8-044F37879DEB

P3181

Q28757651-87A51CCD-093F-47EE-866B-CC323D9A9B99

P356

Q28757651-017A11EA-AEEB-4C39-A66A-AEDD9BF592F5

P407

Q28757651-5902B229-EEAA-4CF2-9619-C480D283AF1E

P433

Q28757651-D296B20C-C934-4C8E-9BFD-1C3239398D41

P478

Q28757651-4DAF7B0E-9AB1-4B7E-A304-705D92B116B7

P50

Q28757651-164BB49C-53E4-45A9-97B4-DC7B0AABA3DA

Q28757651-17B2DF3E-BE97-498C-B9BA-FBBD6E2AE933

Q28757651-627A8C93-D69D-4D25-ADED-08D902137C55

Q28757651-6A1B9104-29DE-4EC4-BD50-54968C944881

Q28757651-7AD799C9-396C-4CAF-930A-6C50BD030F3F

Q28757651-A275291B-D07D-4520-8E4D-AF7444FBD8DC

Q28757651-B685F35A-95CB-4DC7-A354-1412232D3306

P577

Q28757651-402B9949-70A9-48C0-A683-EDBDAAFA9983

P5875

Q28757651-0B5B36FC-C088-4990-9592-043C872388DD

P698

Q28757651-789E38AD-6C5E-439E-9045-F92AB056263F

P921

Q28757651-E1C001F2-6695-4973-8EA4-91F8911CAD56

P932

Q28757651-1AA0FA04-F31D-4E12-A7DA-9408330A07F5

P3181

P356

JOURNAL.PMED.0040178

P1433

P1476

Prophylactic and therapeutic e ...... ibodies against H5N1 influenza

@en

P2093

Amorsolo L Suguitan

http://www.w3.org/2001/XMLSchema#string

Do Quang Ha

http://www.w3.org/2001/XMLSchema#string

Jerrold M Ward

http://www.w3.org/2001/XMLSchema#string

Kimberly Mills

http://www.w3.org/2001/XMLSchema#string

Menno D de Jong

http://www.w3.org/2001/XMLSchema#string

Nadia L Bernasconi

http://www.w3.org/2001/XMLSchema#string

P2860

Evolution of H5N1 avian influenza viruses in Asia

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution

Epidemiology of WHO-confirmed human cases of avian influenza A(H5N1) infection

Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

Avian influenza A (H5N1) infection in humans

Oseltamivir resistance during treatment of influenza A (H5N1) infection

A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans.

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

Avian flu: isolation of drug-resistant H5N1 virus.

P304

e178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1908766

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.0040178

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Nguyen Van Vinh Chau

Cameron P. Simmons

Antonio Lanzavecchia

Federica Sallusto

P577

2007-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6301127

http://www.w3.org/2001/XMLSchema#string

P698

17535101

http://www.w3.org/2001/XMLSchema#string

P921

P932

1880850

http://www.w3.org/2001/XMLSchema#string